Adagrasib 600mg Tablets for NSCLC KRAS G12C in India

Adagrasib is made to help people with NSCLC who have a certain type of KRAS G12C mutation. The drug is made to go after the changed KRAS protein, which is super important in making some cancers grow. You can get this in 200 mg tablets.

They suggest taking 600 mg two times a day, whether you eat or not. Each bottle has 180 tablets, which should last about a month if you take it as suggested. Adagrasib is an oral therapy that has been developed to improve the treatment outcomes for NSCLC patients carrying the KRAS G12C mutation, providing a targeted approach to managing this challenging cancer.